These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30076633)

  • 1. Hidradenitis suppurativa is treated with low-dose flutamide.
    Li C; Xu H; Zhang X; Zhang W; He Y; Wang B
    J Dermatol; 2019 Feb; 46(2):e52-e54. PubMed ID: 30076633
    [No Abstract]   [Full Text] [Related]  

  • 2. Apremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients.
    Weber P; Seyed Jafari SM; Yawalkar N; Hunger RE
    J Am Acad Dermatol; 2017 Jun; 76(6):1189-1191. PubMed ID: 28522043
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical Benefits Scheme listing of adalimumab for hidradenitis suppurativa: Is hidradenitis suppurativa a life-changing drug or does lifestyle change the drug?
    Vekic DA; Frew JW
    Australas J Dermatol; 2018 Aug; 59(3):e243-e244. PubMed ID: 29285755
    [No Abstract]   [Full Text] [Related]  

  • 4. Canakinumab for Severe Hidradenitis Suppurativa: Preliminary Experience in 2 Cases.
    Houriet C; Seyed Jafari SM; Thomi R; Schlapbach C; Borradori L; Yawalkar N; Hunger RE
    JAMA Dermatol; 2017 Nov; 153(11):1195-1197. PubMed ID: 28854317
    [No Abstract]   [Full Text] [Related]  

  • 5. Spironolactone therapy for hidradenitis suppurativa.
    Quinlan C; Kirby B; Hughes R
    Clin Exp Dermatol; 2020 Jun; 45(4):464-465. PubMed ID: 31602704
    [No Abstract]   [Full Text] [Related]  

  • 6. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM; Armario-Hita JC
    Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose adalimumab biosimilar (ZRC-3197) in the treatment of hidradenitis suppurativa.
    Patil S
    Indian J Dermatol Venereol Leprol; 2018; 84(6):745-747. PubMed ID: 30289113
    [No Abstract]   [Full Text] [Related]  

  • 8. Thalidomide in Severe Hidradenitis Suppurativa: A Therapeutic Option.
    Hotz C; Sbidian E; Ingen-Housz-Oro S; Chosidow O; Wolkenstein P
    Acta Derm Venereol; 2019 Nov; 99(12):1170-1171. PubMed ID: 31314122
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab.
    Alecsandru D; Padilla B; Izquierdo JA; Fernández-Cruz E; Sánchez-Ramón S
    Arch Dermatol; 2010 Dec; 146(12):1343-5. PubMed ID: 21173317
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V; Mrowietz U
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case series of 20 women with hidradenitis suppurativa treated with spironolactone.
    Lee A; Fischer G
    Australas J Dermatol; 2015 Aug; 56(3):192-6. PubMed ID: 26080895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guselkumab in the treatment of hidradenitis suppurativa: A retrospective chart review.
    Casseres RG; Kahn JS; Her MJ; Rosmarin D
    J Am Acad Dermatol; 2019 Jul; 81(1):265-267. PubMed ID: 30562567
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful Treatment of Severe Recalcitrant Hidradenitis Suppurativa with the Interleukin-17A Antibody Secukinumab.
    Schuch A; Fischer T; Boehner A; Biedermann T; Volz T
    Acta Derm Venereol; 2018 Jan; 98(1):151-152. PubMed ID: 28902952
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term therapy with anakinra in hidradenitis suppurativa in three patients.
    André R; Marescassier H; Gabay C; Pittet B; Laffitte E
    Int J Dermatol; 2019 Nov; 58(11):e208-e209. PubMed ID: 31353451
    [No Abstract]   [Full Text] [Related]  

  • 15. Scientific evidence for the use of current traditional systemic therapies in patients with hidradenitis suppurativa.
    Alhusayen R; Shear NH
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S42-6. PubMed ID: 26470615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial.
    Pelekanou A; Kanni T; Savva A; Mouktaroudi M; Raftogiannis M; Kotsaki A; Giamarellos-Bourboulis EJ
    Exp Dermatol; 2010 Jun; 19(6):538-40. PubMed ID: 19758320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain in Hidradenitis Suppurativa: A Pilot Study.
    Ring HC; Sørensen H; Miller IM; List EK; Saunte DM; Jemec GB
    Acta Derm Venereol; 2016 May; 96(4):554-6. PubMed ID: 26631388
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemoglobin as an indicator of disease activity in severe hidradenitis suppurativa.
    Braunberger TL; Lowes MA; Hamzavi IH
    Int J Dermatol; 2019 Sep; 58(9):1090-1091. PubMed ID: 30094834
    [No Abstract]   [Full Text] [Related]  

  • 19. Determining the optimal dose of infliximab for treatment of hidradenitis suppurativa.
    Oskardmay AN; Miles JA; Sayed CJ
    J Am Acad Dermatol; 2019 Sep; 81(3):702-708. PubMed ID: 31095972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hidradenitis suppurativa.
    Drug Ther Bull; 2016 Sep; 54(9):102-5. PubMed ID: 27585997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.